Effect of disease duration and other characteristics on efficacy outcomes in clinical trials of tocilizumab for rheumatoid arthritis
Rubbert-Roth A, Aletaha D, Devenport J, Sidiropoulos P, Luder Y, Edwardes M, Jacobs J. Effect of disease duration and other characteristics on efficacy outcomes in clinical trials of tocilizumab for rheumatoid arthritis. Rheumatology (Oxford) 2021; 60:682-691.
Jan 1, 2021
Effect of disease duration and other characteristics on efficacy outcomes in clinical trials of tocilizumab for rheumatoid arthritis
Jan 1, 2021
Rheumatology (Oxford) 2021; 60:682-691
Rubbert-Roth Andrea, Aletaha Daniel, Devenport Jenny, Sidiropoulos Paris N, Luder Yves, Edwardes Michael D, Jacobs Johannes W G
more
